KINIKSA PHARMACEUTICALS LTD's ticker is KNSA and the CUSIP is G5269C101. A total of 103 filers reported holding KINIKSA PHARMACEUTICALS LTD in Q3 2021. The put-call ratio across all filers is 1.07 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $363,658 | +25.5% | 20,936 | +2.1% | 0.00% | 0.0% |
Q2 2023 | $289,812 | +26.0% | 20,505 | -4.1% | 0.00% | 0.0% |
Q1 2023 | $230,092 | -7.0% | 21,384 | +29.5% | 0.00% | 0.0% |
Q4 2022 | $247,290 | +48.1% | 16,508 | +27.2% | 0.00% | – |
Q3 2022 | $167,000 | +2285.7% | 12,976 | +2366.9% | 0.00% | – |
Q2 2021 | $7,000 | – | 526 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Opaleye Management Inc. | 1,025,000 | $12,064,000 | 2.56% |
GREAT POINT PARTNERS LLC | 536,738 | $6,317,000 | 1.40% |
Endurant Capital Management LP | 244,125 | $2,873,000 | 0.69% |
HHLR ADVISORS, LTD. | 2,920,023 | $34,369,000 | 0.53% |
Integral Health Asset Management, LLC | 140,000 | $1,648,000 | 0.46% |
Spearhead Capital Advisors, LLC | 235,024 | $2,766,000 | 0.33% |
Jackson Creek Investment Advisors LLC | 77,069 | $907,000 | 0.32% |
RICE HALL JAMES & ASSOCIATES, LLC | 712,807 | $8,390,000 | 0.30% |
Parkman Healthcare Partners LLC | 113,644 | $1,338,000 | 0.30% |
Birchview Capital, LP | 30,000 | $353,000 | 0.23% |